Checkpoint Therapeutics
(NASDAQ) CKPT
Checkpoint Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$41.00K
Net Income (TTM)
$56.51M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
CKPT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Checkpoint Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
24
CEO
James F. Oliviero, III, CFA
Website
www.checkpointtx.comHeadquarters
Waltham, MA 02453, US
CKPT Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-22%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$41.00K
Operating Income
$56.17M
EBITDA
$56.17M
Operating Cash Flow
$31.10M
Capital Expenditure
$0.00
Free Cash Flow
$31.10M
Cash & ST Invst.
$6.60M
Total Debt
$0.00
Checkpoint Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
24
N/A
Net Income
$11.21M
-2.4%
EBITDA
$11.15M
-2.2%
Quarterly Fundamentals
Net Cash
$33.04M
+193.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.17%
N/A
Return on Invested Capital
-2.45%
N/A
Free Cash Flow
$11.69M
-80.5%
Operating Cash Flow
$11.69M
-80.5%